View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Astex Pharmaceuticals, Inc., Celgene Corporation and Takeda Oncology.

A New Wave of Progress in Myelodysplastic Syndromes: Optimizing Outcomes from Diagnosis to Treatment

A New Wave of Progress in Myelodysplastic Syndromes: Optimizing Outcomes from Diagnosis to Treatment

Thursday, September 12, 2019

Dessert and Registration: 7:45PM – 8:00PM Room: Grand Ballroom G-L, Level 4
Scientific Session: 8:00PM – 9:30PM Room: Grand Ballroom G-L, Level 4

Hilton Americas Houston
1600 Lamar Street
Houston, TX 77010


Recent advances in MDS have focused on comprehensive genetic analysis and cataloging of genetic abnormalities. Determination of MDS subtypes is based on recent revisions to the WHO classification scheme. Patient risk is determined using the International Prognostic Scoring System (IPSS). Scoring systems have been further refined for increased accuracy and the revised IPSS (R-IPSS) allows clinicians to categorize patient risk level and aids in determining best therapeutic options. Symptom management remains an integral part of treatment for these patients and guideline revisions include new supportive care options for MDS. Clinical trials are exploring novel therapeutics and new treatment regimens with use of combination therapies or examination of treatment sequences. It is paramount that health care providers remain up to date on forthcoming treatment options to decipher the best therapeutic option for patients.

Together, emerging therapies and changes to prognostic scoring systems have created a practice gap for health care providers treating patients with MDS.

To help you meet this challenge, this symposium will feature a series of case presentations given by prominent experts in the field to discuss the latest data in MDS and the implications for clinical practice. In addition to clinical scenarios, the expert panel will discuss their own preferences, with perspectives on clinical trial data and any important lessons learned from their own practice.

Benefits of Attending

  • Network with you colleagues and clinical experts in the field of myelodyplastic syndromes (MDS)
  • Gain insights from leading clinical experts on established and new developments for the prognosis of MDS
  • Apply the latest evidence, therapies, and treatment strategies to different clinical case scenarios
  • Improve supportive care and quality-of-life management of your patients with symptomatic MDS

Acknowledgement of Commercial Support

This activity is supported by educational grants from Astex Pharmaceuticals, Inc., Celgene Corporation and Takeda Oncology.

Target Audience

This educational program is directed toward the hematologists, medical oncologists, nurse practitioners, nurses, and fellows who treat patients with myelodysplastic syndromes. Physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of MDS will be invited to participate.

Learning Objectives

  • Review tools for MDS classification and risk stratification, based on morphological, clinical, and cytogenetic criteria
  • Evaluate strategies for tailoring therapy for patients with MDS based on risk stratification and patient comorbidities in front-line setting and beyond
  • Translate clinical trial evidence into real-world practice for the management of MDS
  • Assess data from recent clinical trials evaluating efficacy and safety of novel therapies and strategies for treatment of patients with MDS

Activity Chair

Guillermo Garcia-Manero
Guillermo Garcia-Manero, MD
Chief, Section of Myelodysplastic Syndromes
Deputy Chair, Translational Research
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19

I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventive measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities, including providing proof at check in of being 2 weeks removed from receiving a full COVID-19 vaccination or results from a negative COVID-19 viral test taken no more than 3 days prior to the program.

I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.

* By checking this box, you have read and understand the above and agree to its terms.

Calendar of Events
Filter By